About Contact Us Careers

HBsAg Testing Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 3971
Published Date: Aug 21, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Hepatitis B Tests Landscape

Abbott Laboratories
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
F. Hoffman-La Roche AG
Siemens AG
Bio-Rad Laboratories, Inc.
Danaher Corporation
bioMérieux SA
DiaSorin S.P.A.
MedMira Inc.
Fujirebio US, Inc.
Grifols, S.A."

Browse Key Market Insights with Data Illustration:

Hepatitis B Tests Market Size & Share, Growth Analysis 2036

In the News

In 2023, GSK is actively researching ways to enhance the effectiveness of treatment for chronic hepatitis B by combining Bepirovirsen with other therapies, including pegylated interferon, vaccines, and inhibitors of the PAPD5 and PAPD7 enzymes.
March 2021- Roche and Dicerna started Phase II trial of GalXC RNAi candidate, RG6346, for treating chronic hepatitis B virus (HBV) infection.

Author Credits: Radhika Pawar

Report ID: 3971
Published Date: Aug 21, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of hepatitis B tests is assessed at USD 1.39 billion.

Hepatitis B Tests Market size was valued at USD 1.33 billion in 2023 and is likely to reach USD 2.77 billion by 2036, registering around 5.8% CAGR during the forecast period i.e., between 2024-2036. The market growth is driven by growing prevalence of hepatitis B, and increasing awareness among about early detection of the disease.

Asia Pacific industry is estimated to dominate majority revenue share by 2036, backed by large number of patients, and growing occurrence of hepatitis in the region.

The major players in the market are Abbott Laboratories, F. Hoffman-La Roche AG, Siemens AG, Bio-Rad Laboratories, Inc., Danaher Corporation, and others.

Inquiry Before Buying Request Free Sample